References
- 1. Sarris A.H., Papadimitrakopoulou V., Dimopoulos M.A., Smith T., Pugh W., Ha C.S., McLaughlin P., Callender D., Cox J., Cabanillas F. - Primary parotid lymphoma: the effect of International Prognostic Index on outcome. Leuk Lymphoma., 1997;26(1-2):49-56.
- 2. Gleeson M.J., Bennett M.H., Cawson R.A. - Lymphomas of salivary glands. Cancer, 1986;58(3):699-704.
- 3. Harris N.L. - Lymphoid proliferations of the salivary glands. Am J Clin Pathol., 1999;111(1 Suppl 1):S94-S103.
- 4. Ampil F.L., Misra R.P. - Malignant lymphoma of the salivary gland: Case reports and review of the literature. Radiat Med., 1987;5(1):20-26.
- 5. Ekstrom Smedby K., Vajdic C.M., Falster M., Engels E.A., Martinez-Maza O., Turner J., et al. - Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood, 2008;111(8):4029-4038. doi: 10.1182/blood-2007-10-119974. Epub 2008 Feb 8.
- 6. Tomita N. - BCL2 and MYC dual-hit lymphoma/leukemia. J Clin Exp Hematop., 2011;51(1)7-12.
- 7. Almothafar B., Wong L., Noorafidah M.D. - Primary large B cell lymphoma of the parotid gland: Case report. JUMMEC, 2011;14(1):26-30.
- 8. Samanta M., Ratha B., Mallik A.K., Mishra M. - Disseminated non-Hodgkin’s lymphoma presenting as unilateral parotid gland enlargement with facial nerve palsy. Med J DY Patil Univ., 2014;7(5):683-685.
- 9. Dispenza F., Cicero G., Mortellaro G., Marchese D., Kulamarva G., Dispenza C. - Primary non-Hodgkins lymphoma of the parotid gland. Braz J Otorhinolaryngol., 2011;77(5):639-644.
- 10. Faur A., Lazăr E., Cornianu M., Dema A., Lăzureanu C., Mureşan A., Taban S. - Primary malignant non-Hodgkin’s lymphoma of salivary glands. Rom J Morphol Embryol., 2009;50(4):693-699.
- 11. Kim C.S., Choi Y.D., Choi J.S., Bae E.H., Ma S.K. , Kim S.W. - EBV-positive diffuse large B-cell lymphoma in a patient with primary Sjogren’s syndrome and membranous glomerulonephritis. BMC Nephrol., 2012;13:149. doi: 10.1186/1471-2369-12-149.
- 12. Tadashi T. - Primary diffuse large B-cell lymphoma of the submandibular gland. Int J Clin Exp Pathol., 2012;5(2):179-181.
- 13. Freeman C., Berg J.W., Cutler S.J. - Occurrence and prognosis of extranodal lymphomas. Cancer, 1972;29(1):252-260.
- 14. Choi W.W., Weisenburger D.D., Greiner T.C., Piris M.A., Banham A.H., Delabie J., Braziel R.M., Geng H., Igbal J., Lenz G., et al. - A new immunostain algorithm classifies diffuse large B- cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res., 2009;15(17):5494-5502. doi: 10.1158/1078-0432.CCR-09-0113. Epub 2009 Aug 25.
- 15. Coutinho R., Clear A.J., Owen A., Wilson A., Matthews J., Lee A., Alvarez R., Gomez da Silva M., Cabecadas J., Calaminici M., Gribben J.G. - Poor concordance among nine immunohistochemistry classifiers of cell-oforigin for diffuse large B-cell lymphoma: implications for therapeutic strategies. Clin Cancer Res., 2013;19(24):6686-6695. doi: 10.1158/1078-0432.CCR-13-1482. Epub 2013 Oct 11.
- 16. Hans C.P., Weisenburger D.D., Greiner T.C., Gascoyne R.D., Delabie J., Ott G., Muller-Hermelink H.K., Campo E., Braziel R.M., Jaffe E.S., Pan Z., Farinha P., Smith L.M., Falini B., Banham A.H., Rosenwald A., Staudt L.M., Connors J.M., Armitage J.O., Chan W.C. - Confirmation of the molecular classification of diffuse large B- cell Lymphoma by immunohistochemistry using a tissue microarray. Blood, 2004;103(1):275-282. Epub 2003 Sep 22.
- 17. Hwang H.S., Park C.S., Yoon D.H., Suh C., Huh J. - High concordance of gene expression profiling-correlated immunohistochemistry algorithms in diffuse large B-cell lymphoma, not otherwise specified. Am J Surg Pathol., 2014;38(8):1046-1057. doi: 10.1097/PAS.0000000000000211.
- 18. Benesova K., Forsterova K., Votavova H., Campr V., Stritesky J., Velenska Z., Prochazka B., Pytlik R., Trneny M. - The Hans algorithm failed to predict outcome in patients with diffuse large B -cell lymphoma treated with Rituximab. Neoplasma, 2013;60(1):68-73. doi: 10.4149/ neo_2013_010.
- 19. Gutierrez- Garcia G., Cardesa-Salzmann T., Climent F., Gonzalez-Barca E., Mercadal S., Mate J.L., Sancho J.M., Arenillas L., et. al. - Geneexpression profiling and not immunophenotypic algorithms predicts prognosis in patient with diffuse large B-cell lymphoma treated with immunochemotherapy. Blood, 2011;117(18):4836-4843. doi: 10.1182/ blood-2010-12-322362. Epub 2011 Mar 25.
- 20. Sarkozy C., Traverse-Glehen A., Coiffier B. - Double-hit and double-protein- expression lymphomas: aggressive and refractory lymphomas. Lancet Oncol., 2015;16(15):e555-e567. doi: 10.1016/S1470-2045(15)00005-4.
- 21. Lu T.X., Fan L., Wang L., Wu J.Z., Miao K.R., Liang J.H., Gong Q.X., Wang Z., Young K.H., Xu W., Zhang Z.H., Li J.Y. - MYC or BCL2 copy number aberration is a strong predictor of outcome in patients with diffuse large B-cell lymphoma. Oncotarget, 2015;6(21):18374-18388. doi: 10.18632/oncotarget.4073.
- 22. Motllo C., Grau J., Junca J., Ruiz N., Mate J.L., Orna E., Navarro J.T., Vives S., Sancho J.M., Esteban D., Granada I., Feliu E., Ribera J.M., Milla F. - Translocation (3;8)(q27;q24) in two cases of triple hit lymphoma. Cancer Genet Cytogenet., 2010;203(2):328-332. doi: 10.1016/j.cancergencyto. 2010.08.018.
- 23. Pedersen M.O., Gang A.O., Poulsen T.S., Knudsen H., Lauritzen A.F., Nielsen S.L., Gang U.O., Nargaard P. - Double-hit BCL2/MYC translocations in a consecutive chohort of patients with large B-cell lymphoma - a single centre’s experience. Eur J Haematol., 2012;89(1):63-71. doi: 10.1111/j.1600-0609.2012.01787.x. Epub 2012 Apr 26.
- 24. Savage K.J., Johnson N.A., Ben -Neriah S., Connors J.M., Sehn L.H., Farinha P., Horsman D.E., Gascoyne R.D. - MUC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy. Blood, 2009;114(17):3533-3537. doi: 10.1182/blood-2009-05-220095. Epub 2009 Aug 24.